According to newly unsealed legal documents, Boehringer Ingelheim, the manufacturer of the blood-thinning drug Pradaxa were anxious that an internal research paper would damage drug sales and they suggested it should be suppressed. Key Documents Unsealed The key documents were recently made public by Chief Judge David Herndon in Illinois…
Updated: